International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(21), P. 11492 - 11492
Published: Oct. 26, 2024
Breast
cancer
is
a
public
health
concern
worldwide,
characterized
by
increasing
incidence
and
mortality
rates,
requiring
novel
effective
therapeutic
strategies.
Curcumin
bioactive
compound
extracted
from
turmeric
with
several
pharmacological
activities.
multifaceted
anticancer
agent
through
mechanisms
including
the
modulation
of
signaling
pathways,
inhibition
cell
proliferation,
induction
apoptosis,
production
reactive
oxygen
species.
However,
poor
water
solubility
bioavailability
curcumin
create
important
barriers
in
its
clinical
application.
This
review
elaborates
on
potential
breast
treatment,
focusing
efficacy
different
administration
routes
synergistic
effects
other
agents.
The
intravenous
curcumin-loaded
nanoparticles
significantly
improves
outcomes
compared
to
oral
routes.
Innovative
formulations,
such
as
nano-emulsifying
drug
delivery
systems,
have
shown
promise
enhancing
bioavailability.
While
ensures
higher
direct
action
tumor
cells,
it
more
invasive
expensive
than
administration.
Advancing
research
treatment
essential
for
improving
quality
life
patients.
BMC Cancer,
Journal Year:
2020,
Volume and Issue:
20(1)
Published: Aug. 24, 2020
Abstract
Background
Curcumin
is
herbal
compound
that
has
been
shown
to
have
anti-cancer
effects
in
pre-clinical
and
clinical
studies.
The
of
curcumin
include
inhibiting
the
carcinogenesis,
angiogenesis,
tumour
growth.
This
study
aims
determine
Clinical
different
types
cancers
using
systematic
review
approach.
Methods
A
methodology
adopted
for
undertaking
detailed
analysis
cancer
therapy.
results
presented
this
paper
an
outcome
extracting
findings
studies
selected
from
articles
published
international
databases
including
SID,
MagIran,
IranMedex,
IranDoc,
Google
Scholar,
ScienceDirect,
Scopus,
PubMed
Web
Science
(ISI).
These
were
thoroughly
searched,
relevant
publications
based
on
plausible
keywords,
accordance
with
aims,
as
follows:
prevalence,
curcumin,
features,
cancer.
Results
are
derived
several
consumption
chemotherapy
drugs,
highlighting
increases
effectiveness
radiotherapy
which
improving
patient’s
survival
time,
increasing
expression
anti-metastatic
proteins
along
reducing
their
side
effects.
Conclusion
comprehensive
confirms
reduces
or
radiotherapy,
resulting
patients’
quality
life.
number
reported
that,
increased
patient
time
decreased
tumor
markers’
level.
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
154, P. 113621 - 113621
Published: Aug. 29, 2022
Neuroinflammation
is
a
key
pathophysiological
mechanism
implicated
in
the
neurodegenerative
condition.
One
such
condition
implicating
neuroinflammation
traumatic
brain
injury
(TBI).
Over
past
decades,
various
alternative
natural
compounds,
as
curcumin,
have
been
investigated
novel
therapeutic
options
to
mitigate
pathways
and
clinical
sequelae
involved
TBI.
As
main
component
of
turmeric
(Curcuma
longa),
curcumin
has
broad
range
properties
due
its
considerable
antioxidative
anti-inflammatory
actions.
This
review
discusses
pleiotropic
mechanisms,
side
effects,
curcumin's
delivery
central
nervous
system
(CNS),
immunomodulatory
protective
effects
on
Clinical
trials,
vivo,
vitro
studies
were
extracted
from
different
scientific
databases,
including
PubMed,
Scopus,
Google
Scholar,
assess
or
derivatives
Findings
reveal
that
exhibited
some
TBI
via
modulation
cell
signaling
toll-like
receptor-4
(TLR-4),
nuclear
factor
kappa
B
(NF-κB),
Nod-like
receptor
family
proteins
(NLRPs).
Moreover,
upregulates
brain-derived
Neurotrophic
Factor/Tropomyosin
kinase
(BDNF/TrkB)
pathway,
phosphatidylinositol-3-kinase/protein
(PI3K/AKT),
erythroid
2-related
2
(Nrf2),
which
crucial
functions
pathophysiological-mediated
pathways.
Curcumin
displays
beneficial
capacities
models,
although
more
experiments
are
required
clarify
precise
mechanisms
function
PLoS ONE,
Journal Year:
2022,
Volume and Issue:
17(1), P. e0261370 - e0261370
Published: Jan. 18, 2022
Breast
cancer
(BC)
is
one
of
the
most
common
malignant
tumors
found
in
females.
Previous
studies
have
demonstrated
that
curcumin,
which
a
type
polyphenol
compound
extracted
from
Curcuma
longa
underground
rhizome,
able
to
inhibit
survival
cells.
However,
functional
role
and
mechanism
curcumin
BC
are
still
unclear.
The
Cell
Counting
Kit-8
assay
was
performed
examine
effects
on
cell
viability
lines
MDA-MB-453
MCF-7.
levels
lipid
reactive
oxygen
species
(ROS),
malondialdehyde
(MDA)
production,
intracellular
Fe
2+
were
determined
assess
ferroptosis.
Western
blot
analysis
also
carried
out
detect
protein
levels.
Finally,
antitumorigenic
effect
identified
xenograft
tumor
model.
In
present
study,
results
indicated
could
dose-dependently
suppress
both
MCF-7
Further
revealed
facilitated
solute
carrier
family
1
member
5
(SLC1A5)-mediated
ferroptosis
cells
by
enhancing
ROS
levels,
peroxidation
end-product
MDA
accumulation,
vivo
experiments
significantly
hamper
growth.
Collectively,
exhibited
activity
promoting
SLC1A5-mediated
ferroptosis,
suggests
its
use
as
potential
therapeutic
agent
for
treatment
BC.
Biologics,
Journal Year:
2024,
Volume and Issue:
Volume 18, P. 229 - 255
Published: Sept. 1, 2024
Natural
products
have
proven
to
be
promising
anti-cancer
agents
due
their
diverse
chemical
structures
and
bioactivity.This
review
examines
central
role
in
cancer
treatment,
focusing
on
mechanisms
of
action
therapeutic
benefits.Medicinal
plants
contain
bioactive
compounds,
such
as
flavonoids,
alkaloids,
terpenoids
polyphenols,
which
exhibit
various
anticancer
properties.These
compounds
induce
apoptosis,
inhibit
cell
proliferation
cycle
progression,
interfere
with
microtubule
formation,
act
topoisomerase
targets,
angiogenesis,
modulate
key
signaling
pathways,
improve
the
tumor
microenvironment,
reverse
drug
resistance
activate
immune
cells.Herbal
drugs
offer
advantages,
particularly
selective
toxicity
against
cells,
reducing
adverse
side
effects
associated
conventional
chemotherapy.Recent
studies
clinical
trials
highlight
benefits
herbal
medicines
alleviating
effects,
improving
tolerance
chemotherapy
occurrence
synergistic
treatments.For
example,
medicine
SH003
was
found
safe
potentially
effective
treatment
solid
cancers,
while
Fucoidan
showed
anti-inflammatory
properties
that
are
beneficial
for
patients
advanced
cancer.The
current
research
landscape
is
extensive.Numerous
investigating
efficacy,
safety
cancers
lung,
prostate,
breast
hepatocellular
carcinoma.Promising
developments
include
polypharmacological
approach,
combination
therapies,
immunomodulation
improvement
quality
life.However,
there
still
challenges
development
use
natural
drugs,
need
further
into
action,
possible
interactions
optimal
dosage.Standardizing
extracts,
bioavailability
delivery,
overcoming
regulatory
acceptance
hurdles
critical
issues
addressed.Nonetheless,
warrant
investigation
development.Multidisciplinary
collaboration
essential
advance
therapy
integrate
these
mainstream
treatment.
Nutrients,
Journal Year:
2020,
Volume and Issue:
12(3), P. 679 - 679
Published: March 2, 2020
Prostate
cancer
(PCa)
is
a
heterogeneous
disease
and
ranked
as
the
second
leading
cause
of
cancer-related
deaths
in
males
worldwide.
The
global
burden
PCa
keeps
rising
regardless
emerging
cutting-edge
technologies
for
treatment
drug
designation.
There
are
number
options
which
effectively
treating
localised
androgen-dependent
(ADPC)
through
hormonal
surgery
treatments.
However,
over
time,
these
cancerous
cells
progress
to
androgen-independent
(AIPC)
continuously
grow
despite
hormone
depletion.
At
this
particular
stage,
androgen
depletion
therapy
(ADT)
no
longer
effective
rendered
hormone-insensitive
capable
growing
absence
androgen.
AIPC
lethal
type
leads
poor
prognosis
major
contributor
death
rates.
A
natural
product-derived
compound,
curcumin
has
been
identified
pleiotropic
compound
influencing
modulating
diverse
range
molecular
targets
signalling
pathways
order
exhibit
its
medicinal
properties.
Due
such
multi-targeted
behaviour,
benefits
paramount
combating
wide
diseases
including
inflammation
disease.
Curcumin
exhibits
anti-cancer
properties
by
suppressing
growth
survival,
inflammation,
invasion,
cell
proliferation
well
possesses
ability
induce
apoptosis
malignant
cells.
In
review,
we
investigate
mechanism
multiple
receptor
(AR)
signalling,
activating
protein-1
(AP-1),
phosphatidylinositol
3-kinases/the
serine/threonine
kinase
(PI3K/Akt/mTOR),
wingless
(Wnt)/ß-catenin
nuclear
factor
kappa-B
(NF-κB),
B-cell
lymphoma
2
(Bcl-2)
cyclin
D1
implicated
development
progression
both
types
PCa,
ADPC
AIPC.
addition,
role
microRNAs
clinical
trials
on
effects
patients
were
also
reviewed.
Frontiers in Pharmacology,
Journal Year:
2021,
Volume and Issue:
12
Published: Nov. 3, 2021
Traditional
Chinese
medicine
plays
a
significant
role
in
the
treatment
of
various
diseases
and
has
attracted
increasing
attention
for
clinical
applications.
Vascular
affecting
vasculature
heart,
cerebrovascular
disease,
atherosclerosis,
diabetic
complications
have
compromised
quality
life
affected
individuals
increase
burden
on
health
care
services.
Berberine,
naturally
occurring
isoquinoline
alkaloid
form
Rhizoma
coptidis
,
is
widely
used
China
as
folk
its
antibacterial
anti-inflammatory
properties.
Promisingly,
an
number
studies
identified
several
cellular
molecular
targets
berberine,
indicating
potential
alternative
therapeutic
strategy
vascular
diseases,
well
providing
novel
evidence
that
supports
berberine
to
combat
diseases.
The
purpose
this
review
comprehensively
systematically
describe
agent
including
pharmacological
effects,
mechanisms,
pharmacokinetics.
According
data
published
so
far,
shows
remarkable
anti-inflammatory,
antioxidant,
antiapoptotic,
antiautophagic
activity
via
regulation
multiple
signaling
pathways,
AMP-activated
protein
kinase
(AMPK),
nuclear
factor
κB
(NF-κB),
mitogen-activated
silent
information
regulator
1
(SIRT-1),
hypoxia-inducible
1α
(HIF-1α),
endothelial
growth
phosphoinositide
3-kinase
(PI3K),
B
(Akt),
janus
2
(JAK-2),
Ca
2+
channels,
endoplasmic
reticulum
stress.
Moreover,
we
discuss
existing
limitations
give
corresponding
measures.
In
addition,
propose
some
research
perspectives
challenges,
provide
solid
base
from
which
further
can
excavate
effective
drugs
monomers.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(24), P. 13659 - 13659
Published: Dec. 20, 2021
Cancer
is
the
second
leading
cause
of
death
in
humans.
Despite
rapid
developments
diagnostic
methods
and
therapies,
metastasis
resistance
to
administrated
drugs
are
main
obstacles
successful
treatment.
Therefore,
challenge
should
be
diagnosis
design
optimal
therapeutic
strategies
for
patients
increase
their
chances
responding
positively
treatment
life
expectancy.
In
many
types
cancer,
a
deregulation
multiple
pathways
has
been
found.
This
includes
disturbances
cellular
metabolism,
cell
cycle,
apoptosis,
angiogenesis,
or
epigenetic
modifications.
Additionally,
signals
received
from
microenvironment
may
significantly
contribute
cancer
development.
Chemical
agents
obtained
natural
sources
seem
very
attractive
alternatives
synthetic
compounds.
They
can
exhibit
similar
anti-cancer
potential,
usually
with
reduced
side
effects.
It
was
reported
that
compounds
fruits
vegetables,
e.g.,
polyphenols,
flavonoids,
stilbenes,
carotenoids
acetogenins,
might
effective
against
cells
vitro
vivo.
Several
published
results
indicate
activity
on
protein
expression
by
its
influence
transcription
factors.
could
also
involved
alterations
response,
signaling
Such
components
used
our
diet
protection.
this
review,
activities
compounds,
including
properties,
described.
The
proliferation,
signal
transduction
modifications
highlighted.
Inorganic Chemistry,
Journal Year:
2021,
Volume and Issue:
60(16), P. 11739 - 11744
Published: June 8, 2021
Metal–organic
frameworks
(MOFs)
offer
many
opportunities
for
applications
across
biology
and
medicine.
Their
wide
range
of
chemical
composition
makes
toxicologically
acceptable
formulation
possible,
their
high
level
functionality
enables
possible
as
delivery
systems
therapeutics
agents.
Surface
modifications
have
been
used
in
drug
to
minimize
interaction
with
the
bulk,
improving
specificity
targeted
carriers.
Herein,
we
discuss
a
strategy
achieve
tumor-targeting
drug-loaded
MOF
using
"click"
chemistry
anchor
functional
folic
acid
(FA)
molecules
on
surface
N3-bio-MOF-100.
Using
curcumin
(CCM)
an
anticancer
drug,
observed
loading
encapsulation
efficiencies
(DLEs)
24.02
25.64%
after
soaking
N3-bio-MOF-100
CCM
solutions
1
day
3
days,
respectively.
The
success
postsynthetic
modification
FA
was
confirmed
by
1H
NMR
spectroscopy,
Fourier
transform
infrared
spectroscopy
(FTIR),
liquid
chromatography–mass
spectrometry
(LC-MS).
stimuli-responsive
release
studies
demonstrated
increase
released
under
acidic
microenvironments.
Moreover,
cell
viability
assay
performed
4T1
(breast
cancer)
line
presence
CCM@N3-bio-MOF-100
CCM@N3-bio-MOF-100/FA
carriers
confirm
its
biological
compatibility.
In
addition,
cellular
uptake
study
conducted
evaluate
targeting
tumor
cells.